Literature DB >> 27303073

Pen Device for U-500 Insulin; Tamper-Resistant Seals; Dispelling Myths About ISMP.

Michael R Cohen, Judy L Smetzer.   

Abstract

These medication errors have occurred in health care facilities at least once. They will happen again-perhaps where you work. Through education and alertness of personnel and procedural safeguards, they can be avoided. You should consider publishing accounts of errors in your newsletters and/or presenting them at your inservice training programs. Your assistance is required to continue this feature. The reports described here were received through the Institute for Safe Medication Practices (ISMP) Medication Errors Reporting Program. Any reports published by ISMP will be anonymous. Comments are also invited; the writers' names will be published if desired. ISMP may be contacted at the address shown below. Errors, close calls, or hazardous conditions may be reported directly to ISMP through the ISMP Web site (www.ismp.org), by calling 800-FAIL-SAFE, or via e-mail at ismpinfo@ismp.org. ISMP guarantees the confidentiality and security of the information received and respects reporters' wishes as to the level of detail included in publications.

Entities:  

Year:  2016        PMID: 27303073      PMCID: PMC4896328          DOI: 10.1310/hpj5104-279

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  1 in total

1.  Human Regular 500 units/mL Insulin Therapy: A Review of Clinical Evidence and New Delivery Options.

Authors:  David Sze; Jennifer Goldman
Journal:  Clin Diabetes       Date:  2018-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.